Article
Delusional disorder: molecular genetic evidence for dopamine psychosis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Jun 2002
Morimoto Kiyoshi, Miyatake Ryosuke, Nakamura Mitsuo, Watanabe Takemi, Hirao Toru, Suwaki Hiroshi
Abstract excerpt
UNLABELLED: Since delusional disorder is characterized by mono-symptomatic paranoid symptoms, it can be a good clinical model for investigating the dopaminergic mechanism responsible for paranoid symptoms. We examined neuroleptic responses, plasma homovanillic acid (pHVA) and genes of the dopamine receptor (DR) and its synthesizing enzyme (tyrosine hydroxylase: TH) in patients with delusional disorder and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
